AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,576,000 | -29.8% | 210,143 | -14.8% | 1.59% | +16.7% |
| Q1 2022 | $2,244,000 | +30.6% | 246,563 | +0.7% | 1.36% | +78.0% |
| Q4 2021 | $1,718,000 | -22.0% | 244,783 | +26.7% | 0.77% | -4.2% |
| Q3 2021 | $2,203,000 | +6.6% | 193,266 | +49.7% | 0.80% | +17.4% |
| Q2 2021 | $2,067,000 | +39.2% | 129,100 | +55.4% | 0.68% | +18.6% |
| Q1 2021 | $1,485,000 | +68.8% | 83,100 | +27.6% | 0.58% | -13.7% |
| Q4 2020 | $880,000 | – | 65,100 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |